Gierle, Belgium

Marc Gustaaf Celine Verdonck

This inventor holds 33 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 4 EPO patents, primarily in Histone Deacetylase Inhibitors. Top assignee: Janssen Pharmaceutica Nv. Active years: 2001-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Gustaaf Celine Verdonck. Retrieved from https://idiyas.com/inventor/marc-gustaaf-celine-verdonck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 

% Patents Active = 63.6


 

Average Co-Inventor Count = 6.0

ph-index = 10

Forward Citations = 387(Granted Patents)


Location History:

  • Lille, BE (2001 - 2004)
  • Beerse, BE (2013)
  • Gierle, BE (2007 - 2017)

Company Filing History:


Years Active: 2001-2017

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Histone Deacetylase
Inhibitors
Sulfonyl-Derivatives
Aminocarbonyl
Carbonylamino
Indolyl Alkyl Amino
Pyrimidines
Prokinetic Properties
Novel Compounds
Substituted Derivatives
33 patents (USPTO):Explore Patents

Title: Innovation in Medicine: The Contributions of Marc Gustaaf Celine Verdonck

Introduction

Marc Gustaaf Celine Verdonck, based in Gierle, Belgium, is a distinguished inventor with a notable portfolio of 33 patents. His inventive contributions primarily focus on developing novel compounds with significant medical applications, particularly in the field of enzymatic activity inhibition.

Latest Patents

Among his recent innovations, Verdonck has developed patented compounds that serve as inhibitors of histone deacetylase. The first patent details substituted indolyl alkyl amino derivatives as novel inhibitors, emphasizing their enzymatic activity and potential therapeutic uses. His latest inventions encompass compounds of formula (I), where specific components R, R, R, X, and Y are meticulously defined, demonstrating potent histone deacetylase inhibiting activity, along with their preparation, composition, and medicinal applications. Another notable patent reiterates this concept, employing a similar formula while highlighting various components of the compounds.

Career Highlights

Marc works at Janssen Pharmaceutica NV, a prominent player in the pharmaceutical industry known for its research and development of innovative medicines. His contributions in this organization have made a significant impact in the realm of medical inventions.

Collaborations

Throughout his career, Verdonck has collaborated with experts in his field, including notable coworkers Kristof Van Emelen and Sven Franciscus Anna Van Brandt. These collaborations have fostered innovation and led to the successful development of important pharmaceutical compounds.

Conclusion

Marc Gustaaf Celine Verdonck represents a significant figure in the world of medicinal inventions, with a robust portfolio of patents that continue to influence modern medicine. His ongoing contributions through innovative compounds are vital to advancements in pharmaceutical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…